ADI
80
2
MNST
65
3
AEE
74
3
PLD
58
3
XEL
74
3
PFE
50
14
MTCH
68
9
PSA
50
7
SWK
70
6
KMB
59
2
MTB
69
2
NEM
69
-3
CMCSA
44
2
LEG
62
-2
HCA
75
2
RF
53
2
WMB
58
3
WFC
58
4
ALL
58
5
RCL
62
7
ADI
80
2
MNST
65
3
AEE
74
3
PLD
58
3
XEL
74
3
PFE
50
14
MTCH
68
9
PSA
50
7
SWK
70
6
KMB
59
2
MTB
69
2
NEM
69
-3
CMCSA
44
2
LEG
62
-2
HCA
75
2
RF
53
2
WMB
58
3
WFC
58
4
ALL
58
5
RCL
62
7
Financhill
Back

Ascendis Pharma A/S Stock Predictions

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
50

ASND
Ascendis Pharma A/S

Last Price:
$225.07
Seasonality Move:
-0.46%

7 Day Trial

ALL ACCESS PASS

$ 7

Ascendis Pharma A/S Stock Forecast

  • Over the next 52 weeks, Ascendis Pharma A/S has on average historically risen by 31.2% based on the past 11 years of stock performance.
  • Ascendis Pharma A/S has risen higher in 8 of those 11 years over the subsequent 52-week period, corresponding to a historical accuracy of 72.73%
  • Is Ascendis Pharma A/S Stock Undervalued?
    The current Ascendis Pharma A/S [ASND] share price is $225.00. The Score for ASND is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
  • ASND is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Ascendis Pharma A/S Stock Go Up Next Year?

  • Over the next 52 weeks, Ascendis Pharma A/S has on average historically risen by 31.2% based on the past 11 years of stock performance.

Ascendis Pharma A/S Stock Rating

Sell
50
Ascendis Pharma A/S (ASND) is a Sell

Is Ascendis Pharma A/S overpriced?

  • Ascendis Pharma A/S has risen higher in 8 of those 11 years over the subsequent 52-week period, corresponding to a historical accuracy of 72.73%

Ascendis Pharma A/S Stock Price History

Is ASND stock going to rise?

  • The current trend is moderately bullish and ASND is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
Denmark
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
ascendispharma.com

52-Week Data

52-Week High:
242.00
52-Week Low:
124.06

Prediction Charts

Market Cap:
13.8B
Price in USD:
225.00
Volume:
950.5K
Beta:
0.59

Technical Analysis

SMA50:
216.07
SMA100:
210.66
SMA200:
194.68
52-Wk Change:
45.56%

Stock Predictions

  • Is Ascendis Pharma A/S stock public?
    Yes, Ascendis Pharma A/S is a publicly traded company.
  • What is the Ascendis Pharma A/S stock quote today?
    The Ascendis Pharma A/S stock price is 225.00 USD today.
  • How to buy Ascendis Pharma A/S stock online?
    You can buy Ascendis Pharma A/S shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Feb-2 225.67 223.59 230.68 222.00
Feb-3 223.78 224.67 227.95 222.21
Feb-4 223.66 219.73 225.90 216.71
Feb-5 220.31 217.38 227.18 215.51
Feb-6 217.73 222.15 223.24 212.70
Feb-9 220.92 222.03 226.40 219.44
Feb-10 221.54 224.19 225.19 213.02
Feb-11 221.83 221.49 224.90 214.60
Feb-12 211.00 218.10 222.99 211.00
Feb-13 217.85 216.32 221.80 213.02
Feb-17 217.43 223.41 225.87 216.10
Feb-18 222.55 226.83 228.98 221.67
Feb-19 226.06 230.21 230.98 222.80
Feb-20 230.52 225.00 230.52 221.00

Ascendis Pharma A/S Earnings

Ascendis Pharma A/S Earnings Report: Per Share Ascendis Pharma A/S Earnings Q1 Q2 Q3 and Q4 last year and next year.

Ascendis Pharma A/S Forecast Revenue Growth

Ascendis Pharma A/S Stock Analysis: Historical quarterly revenues per share for Ascendis Pharma A/S and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $1.92 per share, an increase next quarter of $0.11 per share, an increase this year of $9.36 per share, and an increase next year of $7.23 per share.

* Ascendis Pharma A/S stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.